Co-Authors
This is a "connection" page, showing publications co-authored by HEATH SKINNER and JAN KEMNADE.
Connection Strength
0.330
-
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population. Oral Oncol. 2023 10; 145:106536.
Score: 0.229
-
Oropharyngeal cancer outcomes correlate with p16 status, multinucleation and immune infiltration. Mod Pathol. 2022 08; 35(8):1045-1054.
Score: 0.052
-
Metformin generates profound alterations in systemic and tumor immunity with associated antitumor effects. J Immunother Cancer. 2021 07; 9(7).
Score: 0.049